Suppression of miR-374c-5p, in turn, promoted proliferation, migration, and invasion of cells by activating glutamate metabotropic receptor 3 (GRM3) expression [219], which is a glutamate receptor modulating glutamate processing and has been shown to drive breast cancer cell metastasis [244]. Here, GRM3 is linked to breast cancer.